Skip to main content
Market intelligence
CLOVHealthcare

Clover Health Investments Corp insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 17, 2026Jamie L. ReynosoCEO, Medicare AdvantageSale2,360$4.78$11,281
Jun 16, 2026Joseph Frank OldakowskiVP OF FINANCE AND CONTROLLERSale12,102$4.86$58,816
Jun 15, 2026Jamie L. ReynosoCEO, Medicare AdvantageSale6,350$4.61$29,274